July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Akhil Kapoor: We Acknowledge and Appreciate the Trial’s Bold and Innovative Approach in Challenging Established Treatment Paradigms
Jul 9, 2025, 18:16

Akhil Kapoor: We Acknowledge and Appreciate the Trial’s Bold and Innovative Approach in Challenging Established Treatment Paradigms

Akhil Kapoor, Professor of Medical Oncology at Tata Memorial Centre, shared on LinkedIn:

“Pleased to share our recent correspondence in The Lancet Oncology that discusses key concerns related to the SANO trial.

While we raise critical points, we also acknowledge and appreciate the trial’s bold and innovative approach in challenging established treatment paradigms.

Issue 1 – Definition of cCR

  • Lack of universally accepted and reproducible criteria
  • Imaging and biopsy may miss microscopic disease

Issue 2 – Delayed Salvage Surgery

  • Risk of worse outcomes due to tumor progression during surveillance

Issue 3 – Generalizability

  • Highly specialized centers in Netherlands; may not be reproducible in routine practice, especially LMICs

Despite limitations, the SANO trial:

  • Challenges dogma of ‘surgery for all’
  • Promotes patient-centered, organ-preserving approaches
  • Opens door for tailored therapy based on response

Read more here.”

Title: SANO trial: innovations, risks, and unanswered questions

Authors: Akhil Kapoor, Bal Krishna Mishra, Vanita Noronha, Kumar Prabhash

Akhil Kapoor